Table 6 Relationship between CCT2 and PDIA3 expression and clinicopathological characteristics and average survival of gallbladder AC patients

Gender

male

26

9.58(3 to 24)

2.567

0.109

female

54

11.30(3 to 24)

Age (years)

≤ 45

16

10.81(4 to 24)

0.003

0.956

> 45

64

10.72(3 to 24)

Degree of differentiation^a

well-differentiated

27

15.07(5 to 24)

moderately-differentiated

25

10.60(4 to 24)

32.501

0.000

poorly-differentiated

28

6.68(3 to 14)

Tumor maximum diameter (cm)

≤ 3 cm

50

13.70(6 to 24)

68.283

0.000

> 3 cm

30

5.80(3 to 10)

Gallbladder stones

no

42

10.19(3 to 24)

0.246

0.620

yes

38

11.34(4 to 24)

TNM stage

I+II

21

18.96(5 to 24)

III

38

9.29(6 to 15)

105.825

0.000

IV

21

5.14(3 to 7)

Lymph node metastasis

no

30

16.27(4 to 24)

42.372

0.000

yes

50

7.42(3 to 14)

Invasion

no

31

16.68(7 to 24)

55.535

0.000

yes

49

6.98(3 to 11)

Surgical

radical

26

18.31(10 to 24)

palliative

28

8.64(6 to 11)

113.141

0.000

biopsy

26

5.42(3 to 9)

CCT2

-

37

13.78(6 to 24)

17.876

0.000

+

43

8.12(3 to 24)

PDIA3

-

35

13.46(5 to 24)

11.604

0.001

+

45

8.62(3 to 24)